Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Nautilus Biotechnology, Inc. | 160,000 | reported | 02 Mar 2026 | tx 9+870,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Mar 2026 | GRANT_AWARD | Nautilus Biotechnology, Inc. | 160,000 | 0.00 USD | deriv |
| 03 Mar 2025 | GRANT_AWARD | Nautilus Biotechnology, Inc. | 160,000 | 0.00 USD | deriv |
| 01 Mar 2024 | GRANT_AWARD | Nautilus Biotechnology, Inc. | 160,000 | 0.00 USD | deriv |
| 27 Feb 2023 | GRANT_AWARD | Nautilus Biotechnology, Inc. | 160,000 | 0.00 USD | deriv |
| 26 Sept 2022 | PURCHASE | Nautilus Biotechnology, Inc. | 10,000 | 2.03 USD | |
| 27 Sept 2022 | PURCHASE | Nautilus Biotechnology, Inc. | 5,000 | 2.03 USD | |
| 16 Sept 2022 | PURCHASE | Nautilus Biotechnology, Inc. | 35,000 | 2.16 USD | |
| 15 Sept 2022 | PURCHASE | Nautilus Biotechnology, Inc. | 40,000 | 2.19 USD | |
| 25 Feb 2022 | GRANT_AWARD | Nautilus Biotechnology, Inc. | 140,000 | 0.00 USD | deriv |